Taken together, these results indicate that YTHDF2 mediates NONO-TFE3 tRCC progression by recognizing PARP1 mRNA and facilitating the mRNA decay. This evidence concerns the gene PARP1 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.